A multicenter study of body mass index in cancer patients treated with anti-PD-1/PD-L1 immune checkpoint inhibitors: when overweight becomes favorable - Cortellini, A; Bersanelli, M; Buti, S (J Immunother Cancer, 2019)
et al.